Shi, Li et al. found that FTO was highly expressed and promoted proliferation by activating KRAS signaling or upregulating the ubiquitin-specific protease 7 (USP7) in an m6A-dependent manner in NSCLC [17, 18]. The gene discussed is FTO; the disease is non-small cell lung carcinoma.